inflammatory mediators

GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity
Luis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, Benjamin S Dale, Nathania M Figueroa Guilliani, Nicholas A Ullman, Paul R Burchard, Shuyang S Qin, Peter G Juviler, Jessica Millian Keilson, Ashley B Morrison, Mary Georger, Rachel Jewell, Laura M Calvi, Timothy M Nywening, Michael R O'Dell, Aram F Hezel, Luis De Las Casas, Gregory B Lesinski, Jen Jen Yeh, Roberto Hernandez-Alejandro, Brian A Belt, David C Linehan

Gut Aug 2021, gutjnl-2021-324109; DOI: 10.1136/gutjnl-2021-324109
Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium
Michael B Cook, Matthew J Barnett, Cathryn H Bock, Amanda J Cross, Phyllis J Goodman, Gary E Goodman, Christopher A Haiman, Kay-Tee Khaw, Marjorie L McCullough, Christine C Newton, Marie-Christine Boutron-Ruault, Eiliv Lund, Martin Rutegård, Mark D Thornquist, Michael Spriggs, Carol Giffen, Neal D Freedman, Troy Kemp, Candyce H Kroenke, Loïc Le Marchand, Jin Young Park, Michael Simon, Lynne R Wilkens, Ligia Pinto, Allan Hildesheim, Peter T Campbell

Gut Jun 2019, 68 (6) 960-968; DOI: 10.1136/gutjnl-2018-316678
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
F Amicarella, M G Muraro, C Hirt, E Cremonesi, E Padovan, V Mele, V Governa, J Han, X Huber, R A Droeser, M Zuber, M Adamina, M Bolli, R Rosso, A Lugli, I Zlobec, L Terracciano, L Tornillo, P Zajac, S Eppenberger-Castori, F Trapani, D Oertli, G Iezzi

Gut Apr 2017, 66 (4) 692-704; DOI: 10.1136/gutjnl-2015-310016
Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?
André Lechel, Angélique Gougelet

Gut Jul 2016, 65 (7) 1073-1074; DOI: 10.1136/gutjnl-2016-311446
Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
Raquel Franco Leal, Núria Planell, Radhika Kajekar, Juan J Lozano, Ingrid Ordás, Isabella Dotti, Miriam Esteller, M Carme Masamunt, Harsukh Parmar, Elena Ricart, Julián Panés, Azucena Salas

Gut Feb 2015, 64 (2) 233-242; DOI: 10.1136/gutjnl-2013-306518
Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?
Bin Gao, Mingjiang Xu

Gut Nov 2014, 63 (11) 1683-1684; DOI: 10.1136/gutjnl-2013-306603
A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants
Karl G Sylvester, Xuefeng B Ling, G Y Liu, Zachary J Kastenberg, Jun Ji, Zhongkai Hu, Sihua Peng, Ken Lau, Fizan Abdullah, Mary L Brandt, Richard A Ehrenkranz, Mary Catherine Harris, Timothy C Lee, Joyce Simpson, Corinna Bowers, R Lawrence Moss

Gut Aug 2014, 63 (8) 1284-1292; DOI: 10.1136/gutjnl-2013-305130
A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise
Wataru Aoi, Yuji Naito, Tomohisa Takagi, Yuko Tanimura, Yoshikazu Takanami, Yukari Kawai, Kunihiro Sakuma, Liu Po Hang, Katsura Mizushima, Yasuko Hirai, Ryota Koyama, Sayori Wada, Akane Higashi, Satoshi Kokura, Hiroshi Ichikawa, Toshikazu Yoshikawa

Gut Jun 2013, 62 (6) 882-889; DOI: 10.1136/gutjnl-2011-300776
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, Claudia Berger, Marco Londei, Arthur P Bertolino, Gervais Tougas, Simon P L Travis, for the Secukinumab in Crohn's Disease Study Group

Gut Dec 2012, 61 (12) 1693-1700; DOI: 10.1136/gutjnl-2011-301668

Log in using your username and password

Main menu

Log in using your username and password

You are here

inflammatory mediators